NEUROTROPE, INC. : Change in Directors or Principal Officers (form 8-K)

Item 5.02    Departure of Directors or Certain Officers; Election of Directors;
             Appointment of Certain Officers; Compensatory Arrangement of Certain
             Officers.




(b)

On February 21, 2020, James Gottlieb resigned as a member of the Board of Directors (the "Board") of Neurotrope, Inc. (the "Company") and from all committees thereof, effective immediately. Mr. Gottlieb did not indicate any reason for his resignation.

On February 25, 2020, Shana Phares resigned as a member of the Board of Directors of Neurotrope, Inc. (the "Company") and from all committees thereof, effective immediately. Ms. Phares did not indicate any reason for her resignation.

Mr. Gottlieb and Ms. Phares served as the two Board designees of the licensor of the patents and technologies, Cognitive Research Enterprises, Inc. ("CRE"), which licensed the platform technology for Bryostatin to the Company.

© Edgar Online, source Glimpses